56
Participants
Start Date
March 31, 2015
Primary Completion Date
August 31, 2017
Study Completion Date
August 31, 2017
Dapagliflozin
Sodium Glucose Linked Transporter Type 2 (SGLT-2) Inhibitor
Placebo
Capsules containing microcrystalline cellulose Ph Eur overencapsulated in a hard gelatine capsule shell to match the active comparator
Ninewells Hospital and Medical School, Dundee
European Foundation for the Study of Diabetes
OTHER
University of Dundee
OTHER